PCYT1A and lymphoma: As in DLBCL lymphomas, we found in our mAITL mouse model that the neoplastic lymphoma T cells showed a significant upregulation of Pcyt1a, which might represent in addition to Chokα, another target in choline metabolism for anti-cancer treatment.